The nightly ledger

Stock catalysts from the latest SEC filings

Every 8-K, 10-Q and 10-K that AIR's companies filed on SEC EDGAR, and what each one changed in AIR's read. Material filings first, newest first — never ordered by price. For 8-K filing alerts, follow a company and turn on filing emails.

By event type: Acquisitions · Major contracts

Seven-day window, 2 weeks back · Material filings: 1629 · All filings: 1839

Material

Thursday 5 Nov268 filings read · 268 material

  • 8-KFiled 5 Nov 2026All industries

    Skyward Specialty Insurance Group, Inc.SKWD

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show managed premiums up 12.5% YoY, fee-generating premiums up 18.4%, combined ratio of 89.9%, and nine-month operating ROE of 20.4%. Book value per share increased 15.3% since year-end.

    Gap Very high · 58 → Very high · 67

    Progress is running ahead of attention.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Amn Healthcare Services IncAMN

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $717M (+13% YoY) and adjusted EPS of $1.16 (+199% YoY) exceeded guidance. Travel nurse/allied segment grew 27% YoY. Q4 guidance implies 10-12% revenue decline YoY, primarily due to labor disruption normalization.

    Recognition: Balanced 45 → Watch 40Value: Strong 65 → Strong 69Gap Low · 0 → Medium · 14

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    Blackline, Inc.BL

    8-K · Item 2.02 — Results of operations

    BlackLine reported Q3 2026 revenue of $193.4M (+8.5% YoY), GAAP operating margin of 8.6% (vs. 4.3% prior year), and non-GAAP operating margin of 25.9%. RPO grew 14.3% to $1.1B. Dollar-based NRR at 103%. Company raised full-year guidance.

    Value: Strong 65 → Strong 71Gap Low · 0 → Medium · 11

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    AvePoint, Inc.AVPT

    8-K · Item 2.02 — Results of operations

    AvePoint reported Q3 2026 SaaS revenue of $105.5M (+26% YoY), total revenue $131.1M (+19% YoY), and ARR of $495.1M (+27% YoY). GAAP operating margin expanded to 8.7%. Company raised full-year 2026 guidance for ARR, revenue, and non-GAAP operating income.

    Value: Balanced 46 → Watch 43Gap Low · 0 → Low · 7

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    Wynn Resorts LtdWYNN

    8-K · Items 2.02, 8.01 — Results of operations

    Recognition: Balanced 63 → Strong 67Value: Strong 71 → Balanced 50Gap High · 30 → Medium · 11

    The shares became dearer on AIR's value read.

    The gap narrowed — attention is catching up.

    The price trend strengthened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    TIC Solutions, Inc.TIC

    8-K · Item 2.02 — Results of operations

    TIC Solutions reported Q3 2026 record revenue of $639.6M (+35% YoY, +12.5% combined basis), net loss of $11.1M, Adjusted EBITDA of $107.2M (+39% YoY), record backlog of $1.29B (+23% YoY), and raised full-year 2026 revenue guidance.

    Recognition: Balanced 52 → Balanced 57Gap High · 41 → High · 44

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    United Parks & Resorts Inc.PRKS

    8-K · Item 2.02 — Results of operations

    Q3 2026 attendance declined 4.7% YoY to 6.5M guests; total revenue fell 1.1% to $506.5M; net income dropped 10.5% to $80.0M; Adjusted EBITDA decreased 5.1% to $205.1M. Nine-month net income fell 28.8% YoY despite modest revenue decline.

    Recognition: Watch 39 → Balanced 46

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026All industries

    DNOW Inc.DNOW

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $1,337M nearly doubled YoY; adjusted EBITDA of $76M nearly doubled Q1 results. Strong cash generation ($120M operating cash flow), improved leverage (1.1x net debt), and broad-based growth across segments.

    Recognition: Strong 71 → Strong 65Gap Medium · 21 → High · 32

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    ARKO Corp.ARKO

    8-K · Item 2.02 — Results of operations

    ARKO raised FY2026 Adjusted EBITDA guidance to $250–265M (vs. prior range), reported Q3 net income of $14.3M, achieved 12 consecutive quarters of merchandise margin expansion (34.8%), and announced subsidiary APC's $205M acquisition of USPP fuel business expected to add ~280M gallons annually and ~$30M Adjusted EBITDA.

    Gap Very high · 89 → Very high · 92

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Amylyx Pharmaceuticals, Inc.AMLX

    8-K · Item 2.02 — Results of operations

    Amylyx reported positive Phase 3 LUCIDITY results for avexitide in post-bariatric hypoglycemia, meeting primary endpoint with 55% reduction in hypoglycemic events (p=0.000003). NDA submission planned by end-2026. Company raised ~$545M, strengthening balance sheet to $768M.

    Gap High · 35 → High · 43

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Monte Rosa Therapeutics, Inc.GLUE

    8-K · Item 2.02 — Results of operations

    Monte Rosa reported positive Phase 1 results for MRT-8102 showing substantial reduction in inflammatory markers comparable to healthy volunteers with favorable safety. Multiple Phase 2 initiations planned across gout, CAD, and hidradenitis suppurativa. Novartis triggered $87.5M in milestone payments for MRT-6160 Phase 2 studies.

    Gap High · 28 → High · 40

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Nexstar Media Group, Inc.NXST

    8-K · Item 2.02 — Results of operations

    Nexstar reported record Q3 2026 net revenue of $2.1B (+78% YoY), net income of $250M (+285% YoY), and Adjusted EBITDA of $756M (+111% YoY), driven by TEGNA acquisition and record political advertising revenue of $317M.

    Value: Balanced 54 → Strong 65Gap High · 29 → High · 36

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Biotech

    REGENXBIO Inc.RGNX

    8-K · Item 2.02 — Results of operations

    REGENXBIO reported Q3 2026 results with key pipeline milestones: RGX-202 BLA submission on track for Q1 2027 with potential 2H 2027 approval; pivotal wet AMD trial data expected Q4 2026. Cash position strengthened to $251M plus $39M settlement. Revenue declined due to ZOLGENSMA patent expiration, offset by new ITVISMA royalties.

    Value: Weak 15 → Watch 43Gap High · 35 → High · 40

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Radian Group IncRDN

    8-K · Item 2.02 — Results of operations

    Q3 2026: Revenue grew 106% YoY to $624M; diluted EPS $1.28 vs $1.11 prior year; adjusted EPS $1.44 vs $1.15; combined ratio 61%; mortgage insurance in force reached record $286B; specialty segment contributed 57% of net premiums.

    Gap Medium · 20 → High · 27

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Intellia Therapeutics, Inc.NTLA

    8-K · Item 2.02 — Results of operations

    FDA accepted lonvo-z BLA with Priority Review (PDUFA March 10, 2027); completed MAGNITUDE-2 enrollment; secured $400M term loan. Company on track for Q1 2027 commercial launch of first in vivo CRISPR therapy for HAE.

    Gap Very high · 58 → Very high · 63

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Loar Holdings Inc.LOAR

    8-K · Item 2.02 — Results of operations

    Loar reported Q3 2026 record results with net sales up 39% YoY to $176.2M and Adjusted EBITDA up 46.5% to $71.9M. Company raised full-year 2026 and issued 2027 guidance, citing strong order backlog and demand across commercial OEM, aftermarket, and defense end markets.

    Recognition: Balanced 60 → Strong 66Gap Medium · 23 → High · 27

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Janux Therapeutics, Inc.JANX

    8-K · Item 2.02 — Results of operations

    Janux reported Q3 2026 results with improved net loss ($21.6M vs $24.3M YoY), strong cash position ($945.7M), and multiple clinical milestones including first patient dosed in JANX013 combination study and upcoming JANX011 data presentation.

    Recognition: Balanced 52 → Balanced 48Value: Balanced 57 → Balanced 51Gap Medium · 10 → Medium · 22

    Market attention has faded.

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Sana Biotechnology, Inc.SANA

    8-K · Item 2.02 — Results of operations

    Sana reported Q3 2026 results with continued progress toward SC451 Phase 1/2 trial initiation and SG293 clinical study launch. UP421 showed 14-month durability in NEJM publication. Cash position $121.7M with runway into mid-2027. Non-GAAP net loss improved year-over-year.

    Gap Low · 6 → Medium · 19

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    Red Violet, Inc.RDVT

    8-K · Item 2.02 — Results of operations

    Red Violet reported Q3 2026 revenue of $27.8M (+20% YoY), surpassing $100M trailing twelve-month revenue for the first time. Net income grew 29% to $5.4M; operating cash flow increased 25% to $12.7M. Company raised $108.7M in capital via public offering.

    Recognition: Strong 74 → Strong 68Value: Weak 22 → Watch 29

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Helios Technologies, Inc.HLIO

    8-K · Item 2.02 — Results of operations

    Q3 2026 record sales of $230M (+4% YoY, +13% pro-forma), diluted EPS $0.53 (+71%), adjusted EPS $0.80 (+11%). Raised FY2026 sales outlook to $895–$902M (highest in company history). Record operating cash flow $40M (+59%).

    Recognition: Balanced 55 → Balanced 49Value: Watch 38 → Balanced 62

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Banks

    Walker & Dunlop, Inc.WD

    8-K · Item 2.02 — Results of operations

    Gap Very high · 72 → Very high · 65

    The gap narrowed as the filings read less positively.

    The price trend strengthened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026Banks

    Keel Infrastructure Corp.KEEL

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue declined 59% YoY to $28M due to deliberate Bitcoin mining cessation. Net loss of $63M driven by $55M non-cash derivative loss. Company maintains $780M liquidity but faces execution risks on HPC infrastructure pivot and lease negotiations.

    Gap Very high · 53 → High · 40

    The gap narrowed as the filings read less positively.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Core Scientific, Inc./txCORZ

    8-K · Item 2.02 — Results of operations

    Core Scientific reported Q3 2026 colocation revenue of $215.4M, up 57% sequentially, with 485 MW billing capacity and $700M+ annualized revenue run-rate. Adjusted EBITDA tripled to $133.6M with 57% margins. Strong execution on contracted capacity delivery.

    Gap Very high · 77 → Very high · 80

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    Consensus Cloud Solutions, Inc.CCSI

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenues grew 3.7% YoY to $91.0M; Corporate channel exceeded 9% growth. Company narrowed full-year revenue/EBITDA guidance and raised adjusted EPS guidance. Share buybacks and debt repurchase programs active.

    Value: Balanced 54 → Balanced 47Gap Very high · 59 → Very high · 64

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    Kronos Worldwide IncKRO

    8-K · Item 2.02 — Results of operations

    Kronos reported Q3 2026 net income of $34.8M vs. prior-year loss of $37.0M. Nine-month net income of $45.2M vs. loss of $28.1M. Driven by higher sales volumes, market share gains, lower raw material costs, and successful price increases despite end-use demand below historical levels.

    Gap Low · 0 → Low · 3

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    Kayne Anderson BDC, Inc.KBDC

    8-K · Item 2.02 — Results of operations

    Q3 2026 earnings show net investment income of $0.46/share exceeding $0.40 dividend, but NAV declined $0.29/share. Non-accrual investments increased to 3.6% of debt from 2.7%, and realized/unrealized losses totaled $0.36/share, signaling credit stress.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026All industries

    Assured Guaranty LtdAGO

    8-K · Item 2.02 — Results of operations

    AGO reported Q3 2026 net income of $78M ($1.75/share) with strong new business production of $127M GWP and $128M PVP. Financial Guaranty segment showed growth across all three markets, with global structured finance doubling. Adjusted book value per share reached historic highs at $192.60.

    Recognition: Balanced 58 → Balanced 61

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026All industries

    BJs RESTAURANTS INCBJRI

    8-K · Item 2.02 — Results of operations

    BJ's Restaurants reported Q3 2026 results with 8.1% comparable sales growth, 27.9% restaurant-level operating profit increase, and raised full-year 2026 guidance across comparable sales, operating profit, and EBITDA metrics.

    Recognition: Balanced 64 → Balanced 61Gap Low · 0 → Medium · 10

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Prospect Capital CorpPSEC

    8-K · Item 2.02 — Results of operations

    PSEC reported Q3 2026 results with NII of $76.4M ($0.15/share), down from $77.7M prior quarter. Net loss of $53.4M reflects portfolio valuation declines. Company declared $0.035/share monthly distributions and announced $200M share repurchase authorization.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Yelp IncYELP

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue declined 1% YoY to $371M; net income fell to $35M (9% margin) from prior year; Adjusted EBITDA decreased 6% YoY to $92M. Full-year guidance lowered. Advertising revenue remains pressured despite growth in other revenue.

    Gap Medium · 13 → Low · 1

    The gap narrowed — attention is catching up.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Willdan Group, Inc.WLDN

    8-K · Item 2.02 — Results of operations

    News flow: Balanced 51 → Balanced 57Recognition: Balanced 46 → Watch 43Gap High · 27 → Very high · 93

    The filings read more positively.

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Six Flags Entertainment Corporation/NEWFUN

    8-K · Item 2.02 — Results of operations

    Q3 2026 reported revenues down 11% YoY (1.4% same-park growth). Net loss $366M vs. $1.19B prior year (impairment-driven). Adjusted EBITDA down 11.1% reported, up 1.1% same-park. October softened by weather and Six Flags Over Georgia incident; Q4 guidance reduced to $140–150M Adjusted EBITDA vs. $167M prior year.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Genpact LTDG

    8-K · Item 2.02 — Results of operations

    Genpact reported Q3 2026 results with 7.3% YoY revenue growth and Advanced Technology Solutions up 30.3% YoY. Company raised full-year 2026 guidance for gross margin (to ~36.9%, +90 bps) and adjusted diluted EPS growth (to ≥13% YoY).

    Value: Balanced 64 → Balanced 60Gap Low · 3 → Medium · 11

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Trulieve Cannabis Corp.TRLV

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $230M with 64% gross margin; positive net income of $1M. Major milestone: received final DEA registrations for medical marijuana dispensaries under Schedule III rescheduling. Strong cash generation ($183M operating cash flow YTD) and operational expansion.

    Recognition: Weak 15 → Weak 18Gap Low · 0 → Low · 5

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Eve Holding, Inc.EVEX

    8-K · Item 2.02 — Results of operations

    Eve reported Q3 2026 net loss of $58.1M (vs. $46.9M YoY), driven by higher R&D spending on eVTOL development. Engineering prototype completed 73 flights validating 91% of planned checkpoints. Certification progress includes ANAC Basis of Certification published, FAA validation formalized, and EASA application accepted. Cash position of $356M with total liquidity of $470.4M sufficient through 2028.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Hudson Pacific Properties, Inc.HPP

    8-K · Item 2.02 — Results of operations

    HPP reported Q3 2026 results with fifth consecutive quarter of office occupancy growth to 85.6%, executed 534k sq ft of leases, reduced debt 14% YoY, and raised full-year Core FFO guidance to $1.15–$1.21/share from $1.12–$1.20.

    Recognition: Watch 31 → Watch 26Gap High · 28 → High · 43

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Carlyle Group Inc.CG

    8-K · Item 2.02 — Results of operations

    Carlyle reported Q3 2026 results with GAAP net loss of $8M but strong Distributable Earnings of $433M ($1.12/share). AUM grew to $479B; pending fee-earning AUM up 48% YTD. Approaching $100B distributions since 2024; declared $0.35 dividend.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Compass, Inc.COMP

    8-K · Item 2.02 — Results of operations

    Value: Watch 38 → Watch 33Gap High · 38 → High · 44

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    USA TODAY Co., Inc.TDAY

    8-K · Item 2.02 — Results of operations

    Recognition: Balanced 50 → Balanced 54Value: Watch 40 → Weak 24

    More of the market is starting to notice.

    The shares became dearer on AIR's value read.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    El Pollo Loco Holdings, Inc.LOCO

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show revenue growth to $126.3M and positive comp sales of 5.0%, but net income and adjusted EBITDA declined year-over-year. Company guides 2027 expansion of 25-30 new restaurants.

    No notable change in AIR's read.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Banks

    Pra Group IncPRAA

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show net income of $15M vs. loss in prior year, portfolio income up 5%, adjusted cash efficiency improved 200+ bps, and Adjusted EBITDA up 9%. Company issued $400M senior notes extending debt maturity.

    Recognition: Balanced 49 → Watch 42Gap High · 28 → High · 41

    Market attention has faded.

    Progress is running ahead of attention.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Semiconductors

    SYNAPTICS IncSYNA

    8-K · Item 2.02 — Results of operations

    Synaptics reported Q1 FY2027 revenue of $294.0M (up 1% YoY) with GAAP loss of $0.45/share but Non-GAAP EPS of $1.26. Key highlights include new xMCU microcontroller launch and expanded AI partnerships. Pending onsemi all-cash acquisition restructured from all-stock deal.

    No notable change in AIR's read.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Industrials

    DENTSPLY SIRONA Inc.XRAY

    8-K · Item 2.02 — Results of operations

    Q3 2026 net sales declined 7.6% YoY to $836M; adjusted EPS fell 29.4% to $0.29. FY2026 outlook reduced to ~$3.5B sales and $1.20–$1.30 adjusted EPS. Operating cash flow halved; free cash flow collapsed to $0M.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Callaway Golf CoCALY

    8-K · Item 2.02 — Results of operations

    Callaway Golf reported Q3 2026 results exceeding expectations with net sales and Adjusted EBITDA beating guidance. Gross margins expanded significantly (1,210 bps GAAP, 520 bps non-GAAP YoY). Company raised full-year 2026 net sales and Adjusted EBITDA outlook. Operating cash flow increased 45% YTD.

    No notable change in AIR's read.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Icu Medical Inc/DeICUI

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $560.4M (+4.3% YoY) with gross margin expansion to 42% from 37%. GAAP net income of $26.8M vs. prior-year loss; adjusted EPS $2.44 vs. $2.03. Company reaffirms full-year guidance, expecting results at high end of range.

    Gap Low · 3 → Medium · 12

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    Vaalco Energy Inc /De/EGY

    8-K · Item 2.02 — Results of operations

    Q3 2026: Production up 21% QoQ to 20,145 NRI BOPD; sales volumes 5% higher at 1,698 MBOE; Adjusted EBITDAX increased 30% to $71.1M. Gabon Phase Three drilling complete; Baobab field (Côte d'Ivoire) resumed production with first lifting in August; Egypt drilling campaign ongoing. Q4 guidance projects 18% sales volume increase.

    No notable change in AIR's read.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    NorthWestern Energy Group, Inc.NWE

    8-K · Item 2.02 — Results of operations

    Q3 2026 diluted GAAP EPS of $0.50 vs. $0.62 prior year, driven by Colstrip ownership costs and depreciation. Company affirms 2026 guidance ($3.68–$3.83 EPS) and long-term 4–6% growth. Merger with Black Hills pending Montana PSC approval expected by November 12, 2026.

    No notable change in AIR's read.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    Saul Centers, Inc.BFS

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue increased 8.9% to $78.4M, but net income fell 9.7% to $12.6M YoY. Hampden House ramp-up cost $3.7M in net income impact. Same-property NOI grew 5.0%, FFO per share flat at $0.72.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026All industries

    Gibraltar Industries, Inc.ROCK

    8-K · Item 2.02 — Results of operations

    Q3 2026 earnings beat on revenue (+54% via OmniMax acquisition) but adjusted EPS declined 11.4% YoY. Residential organic growth of 3.1% offset by weak end market (-13%). Agtech delayed by permit issues. Full-year 2026 guidance reduced significantly across all metrics.

    Recognition: Watch 43 → Watch 39Value: Watch 27 → Watch 40Gap Very high · 75 → Very high · 70

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    The gap narrowed as the filings read less positively.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Scansource, Inc.SCSC

    8-K · Item 2.02 — Results of operations

    Q1 FY27 net sales grew 30.1% YoY to $962.3M, but operating income fell 52.2% to $12.4M and diluted EPS declined 52.8% to $0.42. Gross margin compressed 238bp to 12.2% due to hardware mix and large deals. Bad debt expense of $4.5M impacted results.

    Fundamentals: Watch 41 → Balanced 47Recognition: Strong 70 → Balanced 61Gap Low · 6 → Low · 0

    The reported numbers improved.

    Market attention has faded.

    The gap closed as the filings read less positively.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    PENN Entertainment, Inc.PENN

    8-K · Item 2.02 — Results of operations

    Q3 2026: Retail segment achieved record revenue ($1.5B) with 33.7% EBITDAR margins; Interactive segment loss narrowed to $18.3M from $76.6M YoY. Consolidated Adjusted EBITDA grew 46% to $284M. Balance sheet deleveraging continued.

    Value: Strong 79 → Strong 69Gap High · 25 → High · 32

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Acacia Research CorpACTG

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue declined 8% YoY to $54.4M; GAAP net loss of $5.6M; Adjusted EBITDA fell 51% YoY to $3.9M. IP Operations revenue collapsed 97% YoY. Offset partially by Benchmark Energy strength and improved per-share cash position.

    Gap Low · 4 → Low · 0

    The gap closed as the filings read less positively.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Strategic Education, Inc.STRA

    8-K · Item 2.02 — Results of operations

    Q3 2026: $134.1M non-cash impairment of ANZ goodwill/intangibles due to international student immigration constraints. Net loss $98.3M vs. $26.6M profit YoY. ETS revenue +12% YoY; USHE enrollment -1.1% YoY; ANZ enrollment -9.1% YoY.

    Recognition: Watch 41 → Watch 37Value: Very strong 80 → Strong 70Gap Low · 4 → Low · 0

    Market attention has faded.

    The shares became dearer on AIR's value read.

    The gap closed as the filings read less positively.

    The price trend weakened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Sonida Senior Living, Inc.SNDA

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show 26.2% Adjusted EBITDA growth, 15.6% same-store NOI increase, occupancy gains of 200 bps to 88.6%, and RevPOR growth of 4.6%. Company completed $150.2M in acquisitions and refinanced debt favorably.

    Gap Very high · 69 → Very high · 74

    Progress is running ahead of attention.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026All industries

    Perimeter Solutions, Inc.PRM

    8-K · Item 2.02 — Results of operations

    Q3 2026 net sales increased 24% to $389.9M; net income swung to $304.5M profit vs. prior-year $90.7M loss. Adjusted EBITDA grew 20% to $223.5M. Company completed Monaco acquisition and rebranded to Perimeter Group Inc.

    Recognition: Balanced 45 → Balanced 48Gap High · 27 → High · 36

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Eplus IncPLUS

    8-K · Items 2.02, 5.02, 8.01 — Results of operations

    ePlus reported Q2 FY2027 results with record gross billings exceeding $1B, net sales up 9.7%, gross profit up 11.2%, and adjusted EBITDA up 14.3%. Company raised full-year FY2027 guidance to upper single digits for net sales/gross profit and low double digits for adjusted EBITDA.

    No notable change in AIR's read.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Industrials

    TransMedics Group, Inc.TMDX

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $203.0M (+41% YoY) exceeded expectations; company raised full-year 2026 guidance to $764–$774M. Net income $17.1M ($0.46/share). Key catalysts include FDA approvals for ENHANCE Heart Part B and DENOVO Lung trials, first European transplant logistics tender win, and OCS Kidney on track for 2H 2027.

    Recognition: Balanced 54 → Strong 67Gap Medium · 12 → Medium · 17

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Corsair Gaming, Inc.CRSR

    8-K · Item 2.02 — Results of operations

    Corsair beat Q3 guidance with $367M revenue (+6% YoY), $17M above high end. Adjusted EBITDA surged 38% to $22.4M. Full-year revenue and EBITDA guidance raised; Q4 outlook strong with double-digit peripheral growth expected.

    Value: Balanced 46 → Balanced 53Gap Low · 4 → Medium · 16

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Biotech

    ARS Pharmaceuticals, Inc.SPRY

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $37.7M exceeded prior year ($32.5M). neffy market share grew to 5% overall, 9% in targeted accounts. Company reduced SG&A 42% QoQ, reaffirmed path to cash flow breakeven by end-2027. Leadership strengthened; ARS-2 Phase 2b on track for Q1 2027 interim data.

    Gap Low · 8 → Medium · 22

    Progress is running ahead of attention.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Celcuity Inc.CELC

    8-K · Item 2.02 — Results of operations

    REVTORPYK (gedatolisib) launched commercially on September 30, 2026, for HR+/HER2- breast cancer. 91% of U.S. commercial/Medicare lives have coverage; 78% of top 36 strategic accounts have ordered. Positive Phase 3 VIKTORIA-1 data for PIK3CA mutant cohort submitted as sNDA.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Viasat IncVSAT

    8-K · Item 2.02 — Results of operations

    Viasat reported Q2 FY2027 results with 3% YoY revenue growth to $1.2B, driven by 20% DAT segment growth. ViaSat-3 Flights 2 and 3 entered service as expected. Free cash flow improved 14% YoY to $78M; net leverage declined 0.3x to 3.2x.

    Recognition: Balanced 63 → Balanced 60Gap Medium · 15 → Medium · 23

    Market attention has faded.

    Progress is running ahead of attention.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    FIDUS INVESTMENT CorpFDUS

    8-K · Item 2.02 — Results of operations

    Q3 2026: Net investment income $0.54/share (18% YoY adjusted growth), total investment income $45.9M (+23% YoY). Board declared $0.54/share total dividends (base $0.43 + supplemental $0.11) for Q4. Portfolio $1.4B across 99 companies; NAV $19.47/share.

    Gap Medium · 23 → High · 38

    Progress is running ahead of attention.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    JFrog LtdFROG

    8-K · Item 2.02 — Results of operations

    JFrog reported Q3 2026 revenue of $179.2M (+31% YoY), cloud revenue $101.5M (+60% YoY), and raised FY2026 guidance. Net dollar retention 124%, customers with $1M+ ARR grew 58% YoY to 112. Strong cash generation and platform adoption.

    Recognition: Strong 68 → Strong 72Value: Weak 16 → Weak 9Gap Low · 3 → Low · 9

    More of the market is starting to notice.

    The shares became dearer on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Enliven Therapeutics, Inc.ELVN

    8-K · Item 2.02 — Results of operations

    Enliven achieved FDA alignment on ENABLE-2 Phase 3 trial design for relcobatinib in CML, on track to initiate before year-end 2026. Strong cash position of $884M supports runway into 2030. R&D expenses increased YoY.

    Recognition: Balanced 57 → Balanced 60Gap Medium · 21 → High · 27

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Lb Pharmaceuticals IncLBRX

    8-K · Item 2.02 — Results of operations

    LB Pharmaceuticals reported Q3 2026 results with $403.8M cash runway extending beyond Q2 2029. Lead asset LB-102 Phase 3 NOVA-2 trial in schizophrenia on track for 1H 2027 topline data. Completed $150M private placement and appointed experienced CMO and CFO.

    No notable change in AIR's read.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    Cbl & Associates Properties IncCBL

    8-K · Item 2.02 — Results of operations

    CBL reported Q3 2026 results with same-center NOI up 3.8%, FFO adjusted per share up 23% YoY, portfolio occupancy up 130 bps to 91.5%, and comparable lease spreads of 6.8%. Company raised full-year guidance twice.

    Recognition: Balanced 48 → Watch 44

    Market attention has faded.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Xeris Biopharma Holdings, Inc.XERS

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue grew 44% YoY to $107M, led by Recorlev (+93% to $71M). Company raised FY2026 guidance to $395–$405M and 2030 outlook to >$1B. Net income $11.3M vs $0.6M prior year; Adjusted EBITDA $30.8M.

    Gap Low · 6 → Medium · 12

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    Celsius Holdings, Inc.CELH

    8-K · Item 2.02 — Results of operations

    Celsius Holdings reported record Q3 2026 revenue of $847.2M (+17% YoY), driven by Alani Nu growth (+24%) and international expansion (+78%). CELSIUS brand declined 6% due to optimization. Gross margin compressed 450 bps to 46.8% from commodity inflation and DSD mix shift.

    Gap Very high · 76 → Very high · 80

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    EPAM Systems, Inc.EPAM

    8-K · Items 2.02, 8.01 — Results of operations

    Q3 2026 revenues $1.426B (+2.3% YoY), GAAP EPS $2.53 (+32.5%), non-GAAP EPS $3.51 (+14.0%). Operating margins expanded. Board approved $1.8B repurchase authorization; $500M ASR planned. Full-year guidance raised; 50% free cash flow return commitment through 2029.

    Recognition: Watch 43 → Balanced 48

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Trupanion, Inc.TRUP

    8-K · Item 2.02 — Results of operations

    Q3 2026 earnings show record cash flow, seventh consecutive quarter of retention improvement, 11% revenue growth to $405.6M, and net income of $9.3M ($0.21 EPS). Company repurchased $25M stock and holds $396.8M cash.

    Gap Medium · 19 → High · 27

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Barings BDC, Inc.BBDC

    8-K · Item 2.02 — Results of operations

    Barings BDC reported Q3 2026 results with net investment income of $0.26 per share covering its dividend. NAV per share remained stable at $10.92. Portfolio grew to $2.5B with $196M funded investments. Board declared $0.26 quarterly dividend.

    No notable change in AIR's read.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Main Street Capital CORPMAIN

    8-K · Item 2.02 — Results of operations

    Q3 2026 earnings: NII $0.89/share, DNII $0.96/share, NAV $34.22/share (+0.9% QoQ). Declared 3.9% increase in Q4 regular monthly dividends and 21st consecutive supplemental dividend of $0.30/share. ROE 14.7% annualized.

    Gap Very high · 61 → Very high · 67

    Progress is running ahead of attention.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Chimera Investment CorpCIM

    8-K · Item 2.02 — Results of operations

    Q3 2026: GAAP net loss of $194M ($2.31/share); book value fell to $14.82/share; economic return of -13.98%. Significant mark-to-market losses on financial instruments ($391M) driven by interest rate and mortgage spread volatility.

    Gap High · 38 → Medium · 24

    The gap narrowed as the filings read less positively.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Fox Factory Holding CorpFOXF

    8-K · Item 2.02 — Results of operations

    Q3 2026 net sales declined 10.1% YoY to $338.4M. GAAP net loss of $109.6M ($2.61/share) driven by $121.3M divestiture loss. Adjusted net income improved to $0.54/share, but operational headwinds persist: supply disruptions, higher input costs, and AAG/SSG weakness partially offset PVG gains.

    Recognition: Balanced 45 → Balanced 49

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    EverCommerce Inc.EVCM

    8-K · Item 2.02 — Results of operations

    Q3 2026 revenue of $151.4M (+2.7% YoY) missed guidance low end; CEO cited non-MRR delays and weak organic search acquisition. FY2026 guidance reduced to $600M revenue and $170M Adjusted EBITDA. Leadership changes underway; management expects recovery by late 2027.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    Playtika Holding Corp.PLTK

    8-K · Item 2.02 — Results of operations

    Playtika reported Q3 2026 revenue of $673.8M (flat YoY, -7.8% QoQ) and record Adjusted EBITDA of $252.1M (+15.9% YoY). Board concluded strategic review, choosing to remain independent. Reaffirmed full-year guidance.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Chatham Lodging TrustCLDT

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show strong operational momentum: RevPAR surged 8%+ to $161 (all-time Q3 high), net income more than doubled, AFFO per share jumped 31% to $0.46, and margins expanded significantly (GOP +110 bps, Adjusted Hotel EBITDA +190 bps).

    Gap High · 34 → High · 44

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Puma Biotechnology, Inc.PBYI

    8-K · Item 2.02 — Results of operations

    Q3 2026 NERLYNX sales grew YoY to $54.1M despite gross-to-net headwinds. Company raised full-year 2026 net income guidance to $20–$22M (from $17–$20M). R&D spending increased on alisertib trials; cash position strengthened to $108.5M.

    News flow: first measured — Balanced 51Recognition: Balanced 53 → Balanced 48Value: Watch 41 → Balanced 49Gap first measured: Medium · 12

    AIR measured this for the first time; no change to report.

    Market attention has faded.

    The shares became cheaper on AIR's value read.

    The price trend weakened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    N-able, Inc.NABL

    8-K · Item 2.02 — Results of operations

    N-able reported Q3 2026 results with 4.9% YoY revenue growth and 5% ARR growth at constant currency, exceeding guidance. Updated full-year ARR outlook to $558M–$560M. Repurchased ~5% of shares; expanded partnerships and launched AI-powered products.

    Value: Strong 75 → Strong 79Gap Low · 0 → Low · 5

    The shares became cheaper on AIR's value read.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026All industries

    Tecnoglass Holdings Inc.TGLS

    8-K · Item 2.02 — Results of operations

    Tecnoglass reported Q3 2026 record revenue of $310.6M (+19.2% YoY), driven by 31% multi-family/commercial growth. Net income $22.8M ($0.51/share); adjusted net income $27.3M ($0.61/share). Backlog hit record $1.43B (+13.2% YoY). Raised FY2026 guidance.

    Recognition: Watch 40 → Balanced 49Gap Medium · 14 → Medium · 24

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026All industries

    FTAI Infrastructure Inc.FIP

    8-K · Item 2.02 — Results of operations

    Q3 2026 Adjusted EBITDA hit record $95.3M; Long Ridge sale regulatory approval received; $255M USD Group energy logistics acquisition agreed. Despite GAAP net loss of $150M, operational metrics and strategic progress are strong.

    Gap Very high · 70 → Very high · 75

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Apple Hospitality REIT, Inc.APLE

    8-K · Item 2.02 — Results of operations

    Q3 2026 earnings show strong growth: net income up 18.9% YoY, RevPAR up 7.3%, EBITDA margin expanded 210 bps. Company executing portfolio optimization (5 hotels contracted for sale, $72M) and refinanced debt favorably. October preliminary data shows 10% RevPAR growth.

    Gap Medium · 22 → High · 29

    Progress is running ahead of attention.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Warby Parker Inc.WRBY

    8-K · Item 2.02 — Results of operations

    Warby Parker reported Q3 2026 revenue of $244.7M (+10.4% YoY), gross margin of 54.4% (+30 bps), and net income of $5.6M. Active customers grew 3.0% to 2.74M; ARPU increased 6.7% to $342. Company narrowed full-year revenue guidance to $966–976M and reaffirmed Adjusted EBITDA guidance of $117–119M. Intelligent Eyewear pre-orders begin November 12.

    Recognition: Balanced 60 → Strong 71Gap Medium · 10 → Medium · 13

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    F&G Annuities & Life, Inc.FG

    8-K · Item 2.02 — Results of operations

    Q3 2026 adjusted net earnings of $0.74/share declined 39% YoY from $1.22/share. Net sales fell 50% to $1.4B. Adjusted ROE and ROA both declined. Despite record AUM and core retail sales, profitability metrics weakened significantly.

    Recognition: Watch 38 → Watch 43

    More of the market is starting to notice.

    The price trend strengthened.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026Software / SaaS

    Doximity, Inc.DOCS

    8-K · Item 2.02 — Results of operations

    Q2 FY2027 revenue grew 4% YoY to $174.5M, but net income fell 44% to $34.7M. Adjusted EBITDA declined 12% to $88.9M with margin compression from 59.8% to 50.9%. FY2027 guidance reduced at midpoint.

    Recognition: Strong 69 → Balanced 58Gap Low · 3 → Low · 0

    Market attention has faded.

    The gap closed as the filings read less positively.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    McGraw Hill, Inc.MH

    8-K · Item 2.02 — Results of operations

    Recognition: Watch 40 → Watch 35

    Market attention has faded.

    The price trend weakened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Solventum CorpSOLV

    8-K · Item 2.02 — Results of operations

    Solventum reported Q3 2026 results with organic sales decline of 2.8% due to expected ERP cutover timing effects. Company raised full-year adjusted EPS guidance to $7.20–$7.30 and expects organic sales growth toward high end of 2.5–3.0% range. Separation ~90% complete.

    Recognition: Balanced 59 → Strong 67Gap Medium · 13 → Medium · 17

    More of the market is starting to notice.

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Strong
    Material
  • 8-KFiled 5 Nov 2026Industrials

    Karman Holdings Inc.KRMN

    8-K · Item 2.02 — Results of operations

    Karman reported record Q3 2026 revenue of $202M (+66% YoY), net income of $21M (+174% YoY), and adjusted EBITDA of $61M (+60% YoY). Backlog doubled to $1.7B. FY2026 guidance raised to $755–760M revenue and $225–227M adjusted EBITDA.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Regency Centers CorpREG

    8-K · Item 2.02 — Results of operations

    Regency Centers reported Q3 2026 results with FFO of $1.23/share and raised full-year FFO guidance to $4.86–$4.88. Same-property NOI grew 5.1% YoY. Board increased common dividend 6% to $0.80/share. Portfolio 97% leased.

    No notable change in AIR's read.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Avalo Therapeutics, Inc.AVTX

    8-K · Item 2.02 — Results of operations

    Avalo reported Q3 2026 results with positive Phase 2 LOTUS data for abdakibart in hidradenitis suppurativa, planning Phase 3 initiation H1 2027. Strong cash position of $462.8M funds operations into 2029. AVTX-010 IND submission planned H1 2027.

    No notable change in AIR's read.

    More facts
    Momentum: Weak
    Material
  • 8-KFiled 5 Nov 2026All industries

    Carlyle Secured Lending, Inc.CGBD

    8-K · Item 2.02 — Results of operations

    CGBD reported Q3 2026 net investment income of $0.36 per share, fully covering its $0.35 dividend. NAV increased 0.3% to $15.65. Portfolio stable at $2.3B across 180 companies with 10.8% weighted average yield. Q4 dividend declared at $0.35/share.

    Gap Low · 7 → Medium · 19

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026All industries

    Concentra Group Holdings Parent, Inc.CON

    8-K · Items 2.02, 8.01 — Results of operations

    Q3 2026 revenue grew 8.6% YoY to $622.1M; net income surged 36.5% YoY. Company raised FY2026 guidance across revenue, EBITDA, and FCF. Board authorized $250M share repurchase and declared $0.0625 dividend. Credit ratings upgraded.

    No notable change in AIR's read.

    More facts
    Momentum: Very strong
    Material
  • 8-KFiled 5 Nov 2026All industries

    NMI Holdings, Inc.NMIH

    8-K · Item 2.02 — Results of operations

    Q3 2026 net income declined 12% sequentially to $93.5M ($1.23 EPS) from Q2's $105.8M ($1.38 EPS). Loss ratio spiked to 18.7% from 8.3% Q/Q. Insurance claims rose 121% Q/Q to $29.1M. ROE fell to 13.8% from 15.9%.

    Recognition: Balanced 51 → Balanced 46Gap Low · 4 → Low · 0

    Market attention has faded.

    The gap closed as the filings read less positively.

    The price trend weakened.

    More facts
    Momentum: Balanced
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Prothena Corp Public Ltd CoPRTA

    8-K · Item 2.02 — Results of operations

    Q3 2026 results show improved net loss ($16.5M vs $36.5M YoY), $272.2M cash position, and positive clinical data for coramitug (hsCRP biomarker reduction). Phase 3 trials for prasinezumab and coramitug progressing toward 2029 completion.

    No notable change in AIR's read.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026Biotech

    Dyne Therapeutics, Inc.DYN

    8-K · Item 2.02 — Results of operations

    Dyne reported Q3 2026 results with $1.134B cash position sufficient through Q2 2028. Lead candidate z-rostudirsen under FDA priority review (PDUFA Jan 21, 2027); z-basivarsen Phase 1/2 data supports efficacy; four preclinical DMD programs advancing. Higher R&D and G&A expenses reflect commercialization preparations.

    Gap Very high · 58 → Very high · 63

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Watch
    Material
  • 8-KFiled 5 Nov 2026All industries

    Primo Brands CorpPRMB

    8-K · Item 2.02 — Results of operations

    Q3 2026 net sales grew 3.1% to $1.82B with improved gross margin (30.4% vs 29.9%). Adjusted EBITDA increased 1.6% to $411M. Company updated 2026 guidance: Net Sales at midpoint of prior range; Adjusted EBITDA at lower end. Authorized $300M share repurchase program.

    Gap Low · 2 → Low · 9

    Progress is running ahead of attention.

    The price trend strengthened.

    More facts
    Momentum: Balanced
    Material

Research, not tips. Filings come from SEC EDGAR; AIR's read is recomputed every trading day. A price move is shown as a fact beside a filing, never as the reason it is listed.